Phenotypic screen identifies the natural product silymarin as a novel anti-inflammatory analgesic is a research paper published in Molecular Pain (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
New York Stem Cell Foundation
Grant: NYSCF-I-R44
National Institute of Neurological Disorders and Stroke
Grant: DP2-NS106664
NINDS NIH HHS
Grant: DP2 NS106664
National Institutes of Health
Grant: 1DP2NS106664-01
A Human Stem Cell-Derived Neuromuscular Junction Model for Amyotrophic Lateral Sclerosis
FWCI
1.10
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Supplemental Material - Phenotypic screen identifies the natural product silymarin as a novel anti-inflammatory analgesic
Phenotypic screen identifies the natural product silymarin as a novel anti-inflammatory analgesic
Phenotypic screen identifies the natural product silymarin as a novel anti-inflammatory analgesic
Supplemental Material - Phenotypic screen identifies the natural product silymarin as a novel anti-inflammatory analgesic